The absorbable surgical sutures market is expected to register USD 3.75 Billion at a CAGR 4.50% during the forecast period (2023 to 2030).
The absorbable surgical sutures market plays a critical role in modern healthcare, offering a range of innovative solutions for wound closure and tissue repair. These sutures, made from biodegradable materials, are designed to be absorbed by the body over time, eliminating the need for removal and reducing the risk of complications associated with non-absorbable sutures. This market encompasses a diverse array of products, including synthetic absorbable sutures, natural absorbable sutures, and combination sutures, catering to the varied needs of surgeons and patients alike.
Market Overview:
The absorbable surgical sutures market is a vital component of the global healthcare industry, providing indispensable tools for wound closure and tissue approximation in various surgical procedures. These sutures, made from biodegradable materials, offer several advantages over traditional non-absorbable sutures, including reduced risk of infection, decreased tissue trauma, and elimination of the need for suture removal. As a result, they have gained significant traction among healthcare professionals and are increasingly preferred in both elective and emergency surgeries.
Key drivers fueling the growth of the absorbable surgical sutures market include the rising prevalence of chronic diseases, increasing surgical procedures globally, and advancements in suture materials and manufacturing technologies. Additionally, growing awareness about the benefits of absorbable sutures, such as reduced tissue trauma, inflammation, and infection rates, is contributing to market expansion.
Regional Analysis
On the basis of region, the absorbable surgical sutures market analysis is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa (MEA).
North America is expected to dominate the market due to the region being an early adopter of latest medical technologies. The rising number of chronic diseases, rate of surgical procedures, and approval granted by federal agencies are factors driving the market growth.
The MEA region can exhibit a tremendous growth rate during the forecast period due to large number of countries investing sufficient funds to improve their healthcare infrastructure. Technological advances in the manufacturing process is likely to spell good fortunes for the market in the region. Development of the medical devices with polymers such as polylactic acid, polydioxanone, and polyester can augur favorably for the global absorbable surgical sutures market.
Segmentation
The global absorbable surgical sutures market has been segmented on the basis of type, structure, application, and end-user.
On the basis of type, the market has been classified as synthetic and natural sutures. Synthetic sutures have been segmented into poliglecaprone suture (Monocryl), vicryl, and polydioxanone suture (PDS). Natural sutures have been segmented into collagen, catgut suture, and polyglycolic acid suture. Among synthetic, the PDS segment can command a high market demand due to its high tensile strength and extended wound support.
On the basis of structure, the market has been classified as monofilament and multifilament sutures.
On the basis of application, the market has been classified as general surgery, cardiovascular surgeries, gynecological surgeries, orthopedic surgeries, and other surgeries.
On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory surgery centers, and others. The high volume of surgeries and first step in emergency care are likely to spike its demand among hospitals, ambulatory surgery centers, and clinics. Sutures are sterilized and safe for prolonged use and will witness high demand in the forthcoming years.
Competition Outlook
absorbable surgical sutures market players of the market include Smith & Nephew plc, 3M Healthcare, B. Braun Melsungen AG, W.L. Gore & Associates, Internacional Farmaceutica, S.A. de C.V., Ethicon Inc., EndoEvolution, LLC, Johnson & Johnson Private Limited, Sutures India Pvt. Ltd., Medtronic plc, Conmed Corporation, Boston Scientific Corporation, Péters Surgical, and DemeTECH Corporation.
About Related Reports:
Africa Malaria Diagnosis and Treatment Market
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
